EUVIMEDEUVIMED entdecken
Leserbrief

Severe HDL Cholesterol Reduction with Bempedoic Acid and Fenofibrate

Francesco Sbrana iD, Federico Bigazzi, Beatrice Dal Pino

New England Journal of Medicine · 27.03.2025 · 392 (12) · 1241-1242

DOI: 10.1056/nejmc2413726 ↗

Kurz gefasst

Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 27.03.2025. Verfasst von Francesco Sbrana und 2 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Toscana Gabriele Monasterio, Pisa, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A reversible interaction between bempedoic acid and fenofibrate leading to a major, reversible decrease in HDL cholesterol levels was found in patients treated for nongenetic elevated LDL cholesterol levels.

Autor:innen und Institutionen

  • Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

ORCID-Profile: Francesco Sbrana

Zitieren

APA

Sbrana, F., Bigazzi, F., & Dal Pino, B. (2025). Severe HDL Cholesterol Reduction with Bempedoic Acid and Fenofibrate. New England Journal of Medicine, 392(12), 1241-1242. https://doi.org/10.1056/nejmc2413726

Vancouver

Sbrana F, Bigazzi F, Dal Pino B. Severe HDL Cholesterol Reduction with Bempedoic Acid and Fenofibrate. New England Journal of Medicine. 2025;392(12):1241-1242. doi:10.1056/nejmc2413726

BibTeX
@article{Sbrana2025,
  author = {Sbrana, Francesco and Bigazzi, Federico and Dal Pino, Beatrice},
  title = {Severe HDL Cholesterol Reduction with Bempedoic Acid and Fenofibrate},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {12},
  pages = {1241--1242},
  doi = {10.1056/nejmc2413726}
}
Kostenlos starten →